Loss of function of triggering receptor expressed on myeloid cell 2 (TREM2), a key receptor selectively expressed by microglia in the brain, contributes to the development of Alzheimer’s disease (AD). This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.